Meeting Enrollment Goals
Meeting Enrollment Goals
3 PagesCASE STUDY Meeting Enrollment Goals Problem-solving Leads to Early Completion of Breast Cancer StudyMeeting Enrollment Goals Problem-solving Leads to Early Completion of Breast Cancer Study A Services F ull Service Indication Breast Cancer Drug Class Chemical Entity Study Phase IIIb Business Segment Real World Solutions Regions North America STUDY DESCRIPTION A randomized, multi-center, double-blind study to compare the efficacy and safety of Study Drug A and Study Drug B asmonotherapy in newly diagnosed partial epilepsy Study Duration 87 months No. of Clincial Sites 115 Patient Population 600 Oncology Outpatient Adult Females A long-standing top 20 pharmaceutical client awarded PRA Health Sciences a Phase IIIb study involving treatment of cancer-related bone loss in pos
